- In February 2025, The Cultivated B, Introduced a new AI-driven biosensor system to enhance real-time monitoring of cell culture and fermentation processes, providing highly precise tracking of growth and metabolic activity
- In March 2025, New Wave Biotech, showcased its AI-powered optimization software, which has driven a 55% cost reduction for its client Multus in biomanufacturing processes, along with significant improvements in product recovery and processing time
- In March 2025, Advanced Instruments announced a definitive agreement to acquire and merge with Nova Biomedical, creating a global life science tools platform with a diversified portfolio of analytical instruments and reagents for biopharmaceutical and clinical markets
- In April 2025, Sonrai Analytics and Paige, announced a strategic partnership to integrate Paige's AI foundation models with Sonrai's cloud-based data analysis and bioinformatics platform, aiming to empower biopharma researchers and clinicians with advanced machine learning capabilities for precision medicine R&D
- In April 2025, Genflow Biosciences PLC and Heureka Labs, signed a master services agreement, providing Genflow Biosciences access to Heureka Labs' proprietary AI platform for analyzing high-dimensional genomic data, enhancing insights into gene regulatory networks for gene therapy research
- In January 2025, OmniaBio Inc. opened a new AI Centre of excellence, aiming to leverage AI to enhance process optimization, reduce costs, improve product quality, and increase production rates for cell and gene therapies
